Your browser doesn't support javascript.
loading
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas.
Morelli, Valentina; Eller-Vainicher, Cristina; Palmieri, Serena; Cairoli, Elisa; Salcuni, Antonio Stefano; Scillitani, Alfredo; Carnevale, Vincenzo; Corbetta, Sabrina; Arosio, Maura; Della Casa, Silvia; Muscogiuri, Giovanna; Spada, Anna; Chiodini, Iacopo.
Afiliación
  • Morelli V; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Eller-Vainicher C; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Palmieri S; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Cairoli E; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Salcuni AS; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Scillitani A; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Carnevale V; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Corbetta S; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Arosio M; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Della Casa S; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Muscogiuri G; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Spada A; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
  • Chiodini I; Department of Medical Sciences and Community Health (V.M., S.P., E.C., M.A., A.S.), University of Milan, Milan, Italy; Unit of Endocrinology and Metabolic Diseases (V.M., C.E.-V., S.P., E.C., A.S., I.C.), IRCCS Cà Granda-Ospedale Maggiore Policlinico Milan, Italy; Unit of Endocrinology (A.S.S., A.S.
J Clin Endocrinol Metab ; 101(7): 2768-75, 2016 07.
Article en En | MEDLINE | ID: mdl-27144939
ABSTRACT
CONTEXT Subtle hypercortisolism is associated with an increased risk of vertebral fracture (VFx).

OBJECTIVE:

The objective was to determine the best parameters of cortisol secretion for detecting the VFx risk in patients with adrenal incidentalomas (AI).

DESIGN:

This was a retrospective (cross-sectional arm) and prospective (longitudinal arm) design. In the cross-sectional arm, we assessed the accuracy of the cortisol secretion indexes in identifying the patients with VFx (prevalent VFx). In the longitudinal arm, we tested the cortisol secretion parameters, which were able to identify the prevalent VFx, for the prediction of the occurrence of a new VFx (incident VFx) in AI patients followed-up for at least 2 years.

SETTING:

Four referral Italian endocrinology units participated in this study. PATIENTS A total of 444 and 126 AI patients without symptoms of hypercortisolism enrolled in the cross-sectional arm and longitudinal arm, respectively. MAIN OUTCOME

MEASURES:

Serum cortisol after a 1-mg dexamethasone suppression test (1 mg DST), urinary free cortisol, ACTH, bone mineral density at lumbar spine and femoral neck (by dual-energy x-ray absorptiometry), and the VFx presence (by x-ray).

RESULTS:

The cortisol levels after 1 mg DST that were greater than 2.0 µg/dl (55 nmol/liter) were the best criteria for detecting patients with both prevalent (73.6% sensitivity, 70.5% specificity) and incident VFx (80% sensitivity, 68.8% specificity) and were associated with a 10-fold increased risk of a new VFx (odds ratio,10.27; 95% confidence interval, 3.39-31.12; P < .0001), regardless of age, gender, bone mineral density at lumbar spine, and prevalent VFx.

CONCLUSIONS:

In AI patients without symptoms of overt hypercortisolism, the cortisol levels after 1 mg DST greater than 2.0 µg/dl (55 nmol/liter) represent the best criterion for detecting prevalent and incident VFx.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hidrocortisona / Fracturas de la Columna Vertebral / Hiperfunción de las Glándulas Suprarrenales / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Año: 2016 Tipo del documento: Article País de afiliación: Samoa Americana

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hidrocortisona / Fracturas de la Columna Vertebral / Hiperfunción de las Glándulas Suprarrenales / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Endocrinol Metab Año: 2016 Tipo del documento: Article País de afiliación: Samoa Americana